Skip to main content

Table 6 Group names and vaccines received on Days 0, 21 and 42

From: A randomized, controlled non-inferiority trial comparing A(H1N1)pmd09 vaccine antigen, with and without AS03 adjuvant system, co-administered or sequentially administered with an inactivated trivalent seasonal influenza vaccine

Group names

Vaccines received

 

Dose 1 (Day 0)

Dose 2 (Day 21)

Dose 3 (Day 42)

Group A

TIV+Placebo

15 μg

15 μg

Group B

TIV+Placebo

3.75 μg/AS03

3.75 μg/AS03

Group C

15 μg+TIV

15 μg

Placebo

Group D

3.75 μg/AS03+TIV

3.75 μg/AS03

Placebo

Group E

15 μg+Placebo

15 μg

TIV

Group F

3.75 μg/AS03+Placebo

3.75 μg/AS03

TIV